Business Segments · Subtotal
Prescription Technology Solutions — Subtotal
McKesson Prescription Technology Solutions — Subtotal increased by 7.0% to $261.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.2%, from $219.00M to $261.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ2 2024
Last reportedQ4 2025
How to read this metric
An increase indicates improved core profitability and operational performance within the technology business.
Detailed definition
This metric serves as an intermediate financial subtotal for the Prescription Technology Solutions segment, often repres...
Peer comparison
Similar to 'segment operating profit' or 'segment income' reported by competitors.
Metric ID:
mck_segment_prescription_technology_solutions_subtotalHistorical Data
6 periods
| Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|
| Value | $203.00M | $205.00M | $219.00M | $253.00M | $244.00M | $261.00M |
| QoQ Change | — | +1.0% | +6.8% | +15.5% | -3.6% | +7.0% |
| YoY Change | — | — | — | +24.6% | +19.0% | +19.2% |
Range$203.00M – $261.00M
CAGR+22.3%
Avg YoY Growth+20.9%
Median YoY Growth+19.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — subtotal?
- McKesson (MCK) reported prescription technology solutions — subtotal of $261.00M in Q4 2025.
- How has McKesson's prescription technology solutions — subtotal changed year-over-year?
- McKesson's prescription technology solutions — subtotal increased by 19.2% year-over-year, from $219.00M to $261.00M.
- What does prescription technology solutions — subtotal mean?
- A subtotal of the segment's financial performance before final corporate adjustments.